UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research

Current pain and headache reports, 2021-11, Vol.25 (11), p.73-73, Article 73

2021

Link zum Volltext

Verfügbarkeit prüfen

The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study

Journal of neurology, 2021-10, Vol.268 (10), p.3789-3798

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

Journal of headache and pain, 2021-12, Vol.22 (1), p.120-120, Article 120

2021

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability

Journal of neurology, 2022-03, Vol.269 (3), p.1456-1462

2022

Link zum Volltext

Verfügbarkeit prüfen

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

Journal of headache and pain, 2021-12, Vol.22 (1), p.151-151, Article 151

2021

Link zum Volltext

Verfügbarkeit prüfen

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution

Cephalalgia, 2020-11, Vol.40 (13), p.1410-1421

2020

Link zum Volltext

Verfügbarkeit prüfen

Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population

Journal of headache and pain, 2024-02, Vol.25 (1), p.21-21

2024

Link zum Volltext

Verfügbarkeit prüfen

Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization

Journal of headache and pain, 2024-04, Vol.25 (1), p.58-58

2024

Link zum Volltext

Verfügbarkeit prüfen

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

Journal of headache and pain, 2020-07, Vol.21 (1), p.90-90, Article 90

2020

Link zum Volltext

Verfügbarkeit prüfen

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

Neurology, 2018-09, Vol.91 (13), p.622

2018

Link zum Volltext

Verfügbarkeit prüfen

Mode and site of action of therapies targeting CGRP signaling

Journal of headache and pain, 2023-09, Vol.24 (1), p.125-125, Article 125

2023

Link zum Volltext

Verfügbarkeit prüfen

Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study

Journal of headache and pain, 2021-07, Vol.22 (1), p.75-75, Article 75

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

Journal of headache and pain, 2023-08, Vol.24 (1), p.104-104, Article 104

2023

Link zum Volltext

Verfügbarkeit prüfen

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse

Frontiers in neurology, 2018-10, Vol.9, p.808-808

2018

Link zum Volltext

Verfügbarkeit prüfen

The state of art on the use of patient reported outcomes in migraine

Current opinion in neurology, 2024-06, Vol.37 (3), p.271

2024

Link zum Volltext

Verfügbarkeit prüfen

Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine

Neurologic clinics, 2021-02, Vol.39 (1), p.1-19

2021

Link zum Volltext

Verfügbarkeit prüfen

Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks

Cephalalgia, 2022-03, Vol.42 (3), p.186-196

2022

Link zum Volltext

Verfügbarkeit prüfen

CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention

Handbook of Clinical Neurology, 2024, Vol.199, p.107-124

2024

Link zum Volltext

Verfügbarkeit prüfen

Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios

Headache, 2021-09, Vol.61 (8), p.1277-1280

2021

Link zum Volltext

Verfügbarkeit prüfen

Virtual issue: COVID‐19 and headache

Headache, 2023-02, Vol.63 (2), p.183-184

2023

Link zum Volltext

Verfügbarkeit prüfen

Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine

Annals of neurology, 2022-11, Vol.92 (5), p.846-859

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study

Cephalalgia, 2023-08, Vol.43 (8), p.3331024231177636-3331024231177636

2023

Link zum Volltext

Verfügbarkeit prüfen

Twenty twenty … two: Headache and COVID‐19

Headache, 2022-06, Vol.62 (6), p.648-649

2022

Link zum Volltext

Verfügbarkeit prüfen

Headache during COVID‐19: Lessons for all, implications for the International Classification of Headache Disorders

Headache, 2021-02, Vol.61 (2), p.385-386

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship of headache as a symptom to COVID‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID‐19

Headache, 2022-09, Vol.62 (8), p.1019-1028

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research

The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution

Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population

Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

Mode and site of action of therapies targeting CGRP signaling

Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse

The state of art on the use of patient reported outcomes in migraine

Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine

Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks

CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention

Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios

Virtual issue: COVID‐19 and headache

Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine

Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study

Twenty twenty … two: Headache and COVID‐19

Headache during COVID‐19: Lessons for all, implications for the International Classification of Headache Disorders

The relationship of headache as a symptom to COVID‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID‐19

Suchergebnisse filtern